Pain ✓100% 1 / 7 · unit 3 of 4
What the card badges mean

✓textbook — checked against your assigned chapter. The standard this exam is measured against.

◆slides — backed by your instructor's own deck, not (yet) the textbook. A different promise, not a lesser one — she writes the exam from these.

○webinar or plain ○ unchecked — nobody has verified this against any source yet. That means unconfirmed, not known wrong.

◐ over any of the above — a caution: only part of the concept is backed, or the wording claims more than its source states.

!conflict — two sources disagree; both versions are on the card.

Tramadol adverse effects

Topic 45 of 67 ✓textbook

On its own, tramadol is fairly gentle. Millions of people have taken it and serious problems are rare, and at normal doses it barely suppresses breathing — which is what sets it apart from the proper opioids.

The usual complaints are drowsiness, dizziness, headache, dry mouth and constipation.

Two things to be careful about. It has triggered seizures in over 280 people, so avoid it in anyone with epilepsy or another neurological condition. And although it is safe at normal doses, an overdose can kill — especially alongside anything else that slows the brain down.

The dangerous combinations all come from how it works. Tramadol is only weakly opioid; mostly it stops nerves reabsorbing noradrenaline and serotonin.

  • Block noradrenaline reuptake, and adding an MAOI can send the blood pressure through the roof. That combination is absolutely forbidden.
  • Block serotonin reuptake, and adding an SSRI, SNRI or tricyclic can cause serotonin syndrome.
  • Alcohol and benzodiazepines make its sedating effects much stronger.

The same mechanism explains something else: naloxone only partly reverses tramadol, because most of what tramadol does is not opioid at all.

That combination is not just "be careful" — tramadol should not be combined with alcohol or benzodiazepines at all.

Serious adverse effects are rare — the danger is almost entirely in what you combine it with.

Used by millions of patients, with serious adverse effects rare. Respiratory depression is minimum at recommended doses, which is what distinguishes it from the pure opioid agonists.

The common side effects:

  • Sedation
  • Dizziness
  • Headache
  • Dry mouth
  • Constipation
Seizures have been reported in more than 280 patients, so tramadol should be avoided in epilepsy and other neurologic disorders. It is generally safe but can be fatal in overdose, especially combined with another CNS depressant.

Three interactions, and one of them is absolute:

WithBecause tramadol…Result
CNS depressants — alcohol, benzodiazepinesintensifies their effectShould not be combined
MAOIsinhibits noradrenaline uptakeHypertensive crisis — ABSOLUTELY contraindicated
SSRIs, SNRIs, tricyclics, MAOIsinhibits serotonin uptakeSerotonin syndrome

Both dangerous interactions come straight from the mechanism: tramadol is an analog of codeine with weak μ agonist activity, but works primarily by blocking uptake of noradrenaline and serotonin. Block those and you have the two interaction lists above. Naloxone only partially blocks tramadol's effects, for the same reason.

Sources for this card

  • ✓Textbook Lehne ch24 §Tramadol — Adverse effects

    Serious effects rare, minimal respiratory depression at recommended doses, the five common side effects, seizures in more than 280 patients with avoidance in epilepsy, and fatality in overdose especially with another CNS depressant.

  • ✓Textbook Lehne ch24 §Tramadol — Drug interactions

    Intensifies CNS depressants; absolutely contraindicated with MAOIs via noradrenaline uptake inhibition causing hypertensive crisis; serotonin syndrome with serotonergic drugs.

  • ✓Textbook Lehne ch24 §Tramadol — Mechanism of action

    A codeine analog with weak mu agonist activity working primarily by blocking noradrenaline and serotonin uptake, which is why naloxone only partially blocks its effects.

  • ◆Slides wk3 s20

    Her own coverage of tramadol among the analgesics.

  • ▣Course module module wk3 §Non-Opioids

    Places tramadol among the analgesics the week covers.

Open one and check this card against it. If it disagrees, that is worth reporting.

Methadone adverse effect

Topic 46 of 67 ✓textbook

Methadone carries two serious warnings, and they are different kinds of danger.

The heart. It stretches out the QT interval, which can tip into a fatal rhythm called torsades de pointes. That has happened at doses of 65 mg a day and above.

  • Be very careful — or do not use it at all — in anyone who already has a long QT, has long QT syndrome in the family, or takes other drugs that stretch the QT.
  • Do an ECG at the start, again later, and then every year.
  • If the QT goes above 500 ms, think about stopping it or lowering the dose.

The breathing. Methadone can suppress breathing severely enough to kill. That is why patients must be told two things very plainly: never take more than prescribed, and stay away from anything else that slows the brain — benzodiazepines, alcohol, and other opioids.

Two black box dangers: it prolongs the QT interval, and it causes severe respiratory depression.

BLACK BOX. Methadone prolongs the QT interval and may therefore cause a potentially fatal dysrhythmia. Torsades de pointes has developed at doses of 65 mg/day or more. It also causes severe, potentially fatal respiratory depression.

Use with great caution — if at all — in:

  • Existing QT prolongation
  • A family history of long QT syndrome
  • Anyone taking other QT-prolonging drugs

Monitoring the QT:

ECG at baseline, once more after starting, then once a year. Above 500 ms, consider stopping methadone or cutting the dose.

What to teach the patient:

  • Never take more than was prescribed.
  • Avoid other CNS depressants — benzodiazepines, alcohol, and other opioids.

That last instruction is the same danger from the other side: the respiratory depression is what kills, and every drug on that list deepens it.

Sources for this card

  • ✓Textbook Lehne ch24 §Methadone black box warning

    QT prolongation with risk of fatal dysrhythmia, torsades reported at 65 mg/day or more, great caution or avoidance in existing QT prolongation, family history of long QT or other QT-prolonging drugs, and severe potentially fatal respiratory depression.

  • ✓Textbook Lehne ch24 §Methadone toxicity

    Gives the ECG schedule including annual monitoring, the 500 ms threshold for stopping or reducing, and the patient instructions on dose and avoiding other CNS depressants.

  • ◆Slides wk3 s22

    Her own coverage of methadone.

  • ▣Course module module wk3 §Opioids

    Places methadone among the opioids the week covers.

Open one and check this card against it. If it disagrees, that is worth reporting.

Treating opioid use disorder

Topic 47 of 67 ✓textbook

Three kinds of drug, and the order matters more than the names.

  • Methadone and buprenorphine are given before someone goes through withdrawal. They stand in for the opioid the person is using, so they can stop the chaos without stopping the drug.
  • Naltrexone is given after supervised withdrawal is finished. It blocks the receptors, so going back to opioids achieves nothing.

Get that order backwards and you cause harm: give a blocker to someone still dependent and you throw them into withdrawal.

Who is allowed to prescribe them differs, and that shapes who gets treated:

  • Methadone for maintenance can only come from a certified opioid treatment programme, approved by the state.
  • Buprenorphine can be prescribed in ordinary primary care by any clinician — including a nurse practitioner — who has done the training and registered.

The details worth memorising: methadone is a full opioid agonist, schedule II, taken once daily. Buprenorphine is an agonist-antagonist, schedule III, taken once daily under the tongue.

Three kinds of drug, and which you use depends on whether withdrawal has happened yet.

ClassDrugWhenWhy
Opioid agonistMethadoneBefore withdrawal — for patients not yet ready for medically supervised withdrawalSubstitutes for the misused opioid
Agonist-antagonistBuprenorphineSame — before withdrawalSubstitutes for the misused opioid
Opioid antagonistNaltrexoneAfter medically supervised withdrawal is completeDiscourages renewed use
Getting that order wrong is the point of the distinction. Substitution drugs come first and stand in for the opioid; the antagonist comes last, once withdrawal is done, and works by making renewed use pointless. Give an antagonist too early and you precipitate withdrawal.

Naltrexone is a pure opioid antagonist, acting at μ and κ receptors — which is how it makes renewed use pointless rather than merely discouraged.

Who may prescribe what — the regulatory split:

  • Methadone maintenance is restricted to certified opioid treatment programmes — certified by SAMHSA and approved by the designated state authority. Schedule II, once a day.
  • Buprenorphine can be written in ordinary primary care by any provider or nurse practitioner who has completed the authorised training and registered with SAMHSA. Schedule III, once a day, sublingual.

That difference in access is why buprenorphine reaches people methadone cannot: one requires a certified programme, the other a trained prescriber in ordinary practice.

Sources for this card

  • ✓Textbook Lehne ch35 §Drugs for long-term management of opioid use disorder

    Names the three classes, gives methadone and buprenorphine as substitutes for patients not yet ready for supervised withdrawal and naltrexone to discourage renewed use afterwards.

  • ✓Textbook Lehne ch35 §Table 35.2

    Methadone maintenance only through SAMHSA-certified opioid treatment programmes approved by the state, schedule II once daily; buprenorphine prescribable in primary care by a trained SAMHSA-registered provider or nurse practitioner, schedule III sublingual once daily.

  • ✓Textbook Lehne ch24 §Pure opioid antagonists

    Pure opioid antagonists act at mu and kappa receptors and produce none of the effects of an agonist.

  • ◆Slides wk3 s26

    Her own coverage of medications for opioid use disorder.

  • ▣Course module module wk3 §Opioid Prescribing and Regulation

    Places OUD treatment among the week's regulatory content.

Open one and check this card against it. If it disagrees, that is worth reporting.

Opioid use disorder

Topic 48 of 67 ✓textbook

Most people who end up misusing opioids started outside medicine, not with a prescription. Only a small minority of people given opioids for pain go on to compulsive use.

There is one striking exception: healthcare staff — doctors, nurses and pharmacists — misuse opioids more than other people with similar education. The reason is simply that they can get hold of them.

The famous "rush" after injecting heroin lasts about 45 seconds. But it is not why people keep using — the long, calm euphoria that follows is.

Tolerance is selective, and that is what makes opioids dangerous:

  • The body gets used to the euphoria, the slowed breathing, and the nausea.
  • It does not get used to constipation or to pinpoint pupils — those stay.
  • Because tolerance to slowed breathing keeps pace with tolerance to the high, taking more to feel the same does not make breathing worse.

Two important limits. Someone tolerant to one opioid is tolerant to others — but that does not extend to alcohol or benzodiazepines, which is why mixing them still kills. And the highest risk of dying is in someone who has not built up tolerance at all.

Two more: most opioids are schedule II controlled substances. And the group that tolerance does not carry over to is barbiturates, benzodiazepines and alcohol — barbiturates included.

Most people who go on to misuse opioids began illicitly — not in a clinic.

Initial exposure happens either recreationally or during pain management in a medical setting. The overwhelming majority who go on to misuse begin their use illicitly, and only a small percentage of those exposed therapeutically develop compulsive use. Most opioids are schedule II.

Health care providers are the exception worth knowing. Providers, nurses and pharmacists as a group misuse opioids more than all other groups with similar educational backgrounds — and the reason given is not stress or knowledge. It is drug access.

Why people continue — and it is not the rush:

Moments after IV injection heroin produces pleasure, relaxation, warmth and thirst — the "rush", lasting about 45 seconds. A long euphoria follows. It is that long tail, not the rush, that keeps people using.

Tolerance is selective, and that shapes the danger:

Tolerance DOES developLittle or no tolerance
EuphoriaConstipation
Respiratory depressionMiosis
Nausea

Tolerance to the slowed breathing builds at the same pace as tolerance to the high — so chasing the same subjective effect with a bigger dose does not make the respiratory depression worse. Cross-tolerance runs between opioids, but NOT to general CNS depressants such as barbiturates, benzodiazepines and alcohol. Risk of respiratory depression and death is greatest in someone who has not built tolerance at all.

Sources for this card

  • ✓Textbook Lehne ch35 §Patterns of use

    Initial exposure is recreational or therapeutic, the overwhelming majority who misuse begin illicitly, only a small percentage of therapeutic users develop compulsive use, and health care providers misuse more than comparable groups primarily because of drug access.

  • ✓Textbook Lehne ch35 §Subjective and behavioral effects

    Describes the 45-second rush and the prolonged euphoria that follows, and states the extended effects rather than the rush are the primary reason for misuse.

  • ✓Textbook Lehne ch35 §Tolerance and physical dependence

    Tolerance develops to euphoria, respiratory depression and nausea but little or none to constipation and miosis; respiratory tolerance parallels euphoric tolerance; cross-tolerance exists between opioids but not with general CNS depressants; and risk is greatest in the non-tolerant.

  • ◆Slides wk3 s25

    Her own coverage of opioid use disorder.

  • ▣Course module module wk3 §Opioids

    Places opioid use disorder among the week's content.

Open one and check this card against it. If it disagrees, that is worth reporting.

Opioid safe prescribing

Topic 49 of 67 ✓textbook

This is about balance, not banning. People in long-term pain that is not cancer do get real benefit from opioids — less pain, better mood, more able to function — and they still have a right to have their pain treated.

The guidelines exist to hold both things at once: their right to relief, and your responsibility not to cause harm.

  • Reach for an opioid only after non-opioid painkillers and more conservative approaches have failed.
  • Talk through the benefits and risks of long-term opioids with the person.

The CDC issued its pain guidelines in 2016; pain-medicine bodies had issued their own before that.

On top of all that sits your state's law, which is where the specifics live. Most states cap how much you can prescribe at once, particularly the first time. Many also require you to educate the patient, check the prescription monitoring database, and do extra training yourself. It differs state by state, so the national guideline is only half the answer.

The problem is a balance, not a prohibition: patients still have a right to effective treatment.

For long-term pain that is not from cancer, opioids genuinely work — less pain, better mood, more function.

The guideline history:

  • The American Academy of Pain Medicine and American Pain Society issued guidelines for opioids in chronic noncancer pain first.
  • The CDC pain guidelines followed in 2016.

Provisions from those earlier guidelines:

  1. Use opioids only after non-opioid analgesics or more conservative methods have failed.
  2. Talk the risks and the benefits through with the patient before committing to long-term use.
State law is a separate layer on top. Most states cap how much may be dispensed on a single prescription, and are strictest on a first one. Many go further and require you to provide patient education, check the prescription drug monitoring website, and obtain additional education on safe prescribing yourself. These vary state to state, so knowing the national guideline is not enough.

So safe prescribing has three tiers: try something else first, document the conversation, and comply with whatever your state additionally requires.

Sources for this card

  • ✓Textbook Lehne ch24 §Prescribing guidelines

    Frames the need to balance patients' rights against prescribers' concerns, dates the CDC guidelines to 2016 after the AAPM and APS ones, and gives the provisions on trying non-opioids first and discussing benefits and risks.

  • ✓Textbook Lehne ch24 §State legislation

    Most state laws limit quantities especially on first prescriptions, and many require patient education, checking prescription drug monitoring websites and further prescriber education.

  • ◆Slides wk3 s28

    Her own coverage of safe opioid prescribing.

  • ▣Course module module wk3 §Opioid Prescribing and Regulation

    Places safe prescribing and regulation among the week's content.

Open one and check this card against it. If it disagrees, that is worth reporting.

Naloxone administration

Topic 50 of 67 ✓textbook

The single most important thing about naloxone: it wears off before the opioid does. One dose is not the treatment.

It has to be given again every few hours until the opioid has dropped to a safe level, and that can take days. People have died after being brought round with naloxone because nobody gave them another dose. Waking up is not the same as being out of danger.

  • Nasal spray — one spray into one nostril, giving 4 to 8 mg. If nothing happens, repeat every 2 to 3 minutes until the ambulance arrives.
  • Prefilled syringe (Zimhi) — one dose into the muscle or skin of the outer thigh, with a fresh syringe every 2 to 3 minutes if needed.

It only became easy to get quite recently: an outpatient version in 2014, a nasal one in 2015, and by 2017 every state had passed a law to widen access — though the rules differ from state to state.

For the record: naloxone is the classic pure opioid antagonist, blocking both μ and κ receptors, and its main job is reversing the slowed breathing and drowsiness of an opioid overdose.

One dose is not the treatment. Naloxone's half-life is short — the opioid outlasts it.

Give it again every few hours until the opioid has fallen to a non-toxic level — which may take DAYS. Skipping the repeat has killed patients who had already been brought round. Someone waking up is not someone who is safe.

Outside hospital — two options for a caregiver:

HowDoseRepeat
Nasal sprayOne spray into one nostril4–8 mgEvery 2–3 minutes until EMS arrives
Prefilled syringe (Zimhi)Into muscle or skin of the outer thighOne cartridgeNew syringe every 2–3 minutes until help arrives

How it became available at all:

  • 2014 — FDA approves the first naloxone preparation intended for outpatient use.
  • 2015 — FDA approves a nasal formulation.
  • 2017 — legislation passed in all 50 states to increase public access, though the laws vary state to state.

Naloxone is the prototype pure opioid antagonist — an antagonist at both μ and κ receptors. Its principal use is reversing the respiratory and CNS depression of an opioid agonist overdose.

Sources for this card

  • ✓Textbook Lehne ch35 §Management of opioid overdose

    Naloxone's short half-life requires readministration every few hours for what may be days, and failure to repeat can kill a patient already rendered symptom-free; gives the nasal spray dose and nostril, the Zimhi thigh route, the 2-3 minute repeat interval, and the 2014, 2015 and 2017 access milestones.

  • ✓Textbook Lehne ch24 §Pure opioid antagonists

    Naloxone is the prototype pure opioid antagonist, acting at mu and kappa receptors, used principally to reverse opioid-induced respiratory and CNS depression.

  • ◆Slides wk3 s30

    Her own coverage of naloxone.

  • ▣Course module module wk3 §Opioid Prescribing and Regulation

    Places naloxone access among the week's prescribing and regulation content.

Open one and check this card against it. If it disagrees, that is worth reporting.

Cannabis adverse effects

Topic 51 of 67 ✓textbook

The active ingredient is THC, an oily substance that dissolves in fat. It is strongest in the flowering tops of female plants and weakest in the seeds. Hashish — the dried resin from those flowers — is a good deal stronger than marijuana itself.

How much it takes to cause problems varies enormously between people. Some are fine on very large amounts; others get side effects at ordinary ones.

Two things happen with long-term use:

  • Amotivational syndrome — apathy, dullness, not looking after yourself, losing interest in achieving anything. Worth being careful here: nobody has established that marijuana actually causes it, and the evidence does not point to brain damage.
  • Cannabinoid hyperemesis syndrome — repeated bouts of nausea and vomiting that are strangely relieved by hot showers or baths. It was first described in 2004 and became familiar as legalisation spread. The only treatment is stopping.

That second one is genuinely odd, and worth remembering for exactly that reason: a lot of people use cannabis to stop feeling sick.

A few specifics: THC stands for delta-9-tetrahydrocannabinol, and the plant is Cannabis sativa, the Indian hemp plant. The psychoactive compounds are present in both male and female plants — the female flowering tops are simply where they are most concentrated.

For scale: in 2021, 2.7 million American adolescents aged 12–17 had used marijuana in the past year, and more than 52 million Americans reported using it.

THC — delta-9-tetrahydrocannabinol — does the psychoactive work. It is oily, and dissolves readily in fat.

From Cannabis sativa, the Indian hemp plant. Psychoactive compounds are in all parts of male and female plants, but the greatest concentration is in the flowering tops of the female plants; the lowest is in the seeds. Hashish — dried resinous exudate from female flowers — is considerably more potent than marijuana.

Individual variation is enormous. Some people experience ill effects only at extremely high doses; others routinely experience adverse effects at moderate doses. There is no single dose at which cannabis becomes harmful.

Effects of chronic use:

  • Amotivational syndrome — apathy, dullness, poor grooming, reduced interest in achievement, disinterest in conventional goals. The precise relationship to marijuana is not known, and available data do not suggest it is due to organic brain damage.
  • Cannabinoid hyperemesis syndrome (CHS) — cyclic nausea and vomiting, often relieved by hot showers or baths, in chronic users. First described in 2004, and only commonly recognised as legalisation spread. The treatment is cessation.

CHS is the paradox worth remembering: the mechanism is unknown, and it is genuinely strange, because many people use marijuana precisely to relieve nausea and vomiting.

Scale: in 2021, 2.7 million American adolescents aged 12–17 had used marijuana in the past year, and more than 52 million Americans reported use.

Sources for this card

  • ✓Textbook Lehne ch35 §Cannabis sativa, the source of marijuana

    Names THC as the major psychoactive substance, oily and highly lipid soluble, concentrated in the flowering tops of female plants and lowest in seeds, with hashish considerably more potent; and gives the 2021 usage figures.

  • ✓Textbook Lehne ch35 §Effects of chronic use

    Describes amotivational syndrome and the absence of an established causal relationship or evidence of brain damage, and cannabinoid hyperemesis syndrome with its hot-shower relief, 2004 description, unknown paradoxical mechanism and treatment by cessation.

  • ◆Slides wk3 s33

    Her own coverage of cannabis.

  • ▣Course module module wk3 §Lifespan Considerations

    Places substance use among the week's content.

Open one and check this card against it. If it disagrees, that is worth reporting.